Articles From: - Texas Instruments ushers in a new era of ultra-low power with new MSP430™ FRAM microcontrollers to - Revance Therapeutics Announces Closing of Its Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

MSP430 MCUs with EnergyTrace++™ technology designed from the ground up to enable the world's lowest power microcontroller systems DALLAS , June 24, 2014 /PRNewswire/ -- Texas Instruments (TI) (NASDAQ: TXN) today announced its comprehensive ultra-low power FRAM microcontroller (MCU) platform with all the necessary hardware and software tools, and support for developers to reduce energy budgets, minimize product size and enable a battery-free world.
Sign-up for - Texas Instruments ushers in a new era of ultra-low power with new MSP430™ FRAM microcontrollers investment picks
CHICAGO , June 24, 2014 /PRNewswire/ -- InformationWeek has launched a unique series of executive events called The Mobile Business Futures Summit, which continues in Chicago on June 24 .
Sign-up for 2014/6/24 - InformationWeek Announces "Mobile Business Futures Summit" in Chicago for Mobile-Conscious Business Executives investment picks
NEW YORK , June 24, 2014 /PRNewswire/ -- Great American Group, Inc. (OTCBB: GAMR) (OTCBB: GAMRD) , today announced the appointment of Daniel Williams as Managing Director of its Advisory and Valuation Services division.
Sign-up for - Daniel Williams Joins Great American Group as Managing Director of its Advisory and Valuation Services Division investment picks
Interlaken Leadership Awards Program Supports Original Research in the Field of Neuroimmunology KING OF PRUSSIA, Pa.
Sign-up for 2014/6/24 - CSL Behring Announces the 2014 Interlaken Leadership Awards Recipient investment picks
Pandora (NYSE:P), the leading internet radio service, announced today that David Gerbitz will join the company as Executive Vice President of Revenue Operations, effective July 7th.
Sign-up for 2014/6/24 - Pandora Hires David Gerbitz as Executive Vice President of Revenue Operations; Announces Departure of General Counsel Delida Costin investment picks
Pioneering Angiogenic Gene Therapy for the Potential Treatment of Millions of Patients with Heart Disease Worldwide SAN DIEGO , June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) will report today at the Biotechnology Industry Organization's 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx ® Ad5FGF-4, Cardium Therapeutics' angiogenic gene therapy product candidate for patients with myocardial ischemia due to coronary artery disease.
Sign-up for 2014/6/24 - Cardium Announces Positive Interim Phase 3 Clinical Data Showing Significant Efficacy of Generx® Angiogenic Gene Therapy for Myocardial Ischemia Due to Coronary Artery Disease at the 2014 BIO International Convention investment picks
Summer jobs at local restaurants, retail stores, medical offices and many other small businesses may be hard to come by for student workers this summer.
Sign-up for 2014/6/24 - Only 1 in 5 Small Businesses are Hiring Student Workers This Summer investment picks
NATICK, Mass., June 24, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) , a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, today announced the initiation of its Phase 2 study of Selinexor (KPT-330) in patients 60 years of age or older with relapsed or refractory acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy and/or transplantation.
Sign-up for - Karyopharm Initiates Registration-Directed, Randomized Study of Selinexor (KPT-330) in Older Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) investment picks
Alter NRG Corp.
Sign-up for 2014/6/24 - Alter NRG Corp. provides an update on its annual open house in Tees Valley, England investment picks
NGC today announced that Supply & Demand Chain Executive Magazine has named NGC to the prestigious Supply & Demand Chain Executive “ 100” for 2014, recognizing the top 100 supply chain projects in the industry.
Sign-up for 2014/6/24 - NGC Named to Supply & Demand Chain Executive “100” for Fourth Consecutive Year investment picks
By Catey Hill, MarketWatch Many cruise lines have been quietly raising automatic gratuities, which means cruisers may be paying out more in tips to cruise staff.
Sign-up for 2014/6/24 - UPDATE: Cruise lines with the best -- and worst -- tipping policies investment picks
Sleeker, faster and packed with more features than ever before, LeapPad3 and LeapPad Ultra XDi are super kid safe, incredibly kid tough and kid smart with access to LeapFrog's world-class educational content library EMERYVILLE, Calif.
Sign-up for 2014/6/24 - LeapFrog Unveils New LeapPad™3 And LeapPad™ Ultra XDi, The Best First Tablet Experiences For Kids investment picks
ATLANTA and AUGUSTA, Ga., June 24, 2014 (GLOBE NEWSWIRE) -- State Bank Financial Corporation (Nasdaq:STBZ) , the holding company for State Bank and Trust Company, and Georgia-Carolina Bancshares, Inc. (OTCQB:GECR) jointly announced today the signing of a definitive agreement for State Bank Financial to acquire Georgia-Carolina Bancshares and its wholly-owned subsidiary, First Bank of Georgia, in a cash and stock transaction with a purchase price of approximately $82 million, or $22.35 per share.
Sign-up for - State Bank Financial Corporation and Georgia-Carolina Bancshares, Inc. Announce Merger investment picks
Walgreen Co.
Sign-up for - Walgreen Co. Reports Fiscal 2014 Third Quarter Results investment picks
Insurance holding company Baldwin & Lyons, Inc. has selected Accenture (NYSE: ACN) to enhance its core insurance system with a software platform that can help consolidate processes for increased efficiencies and faster response to market changes.
Sign-up for - Baldwin & Lyons, Inc. Selects Accenture to Modernize Infrastructure and Streamline Processes Using Duck Creek Software investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from two Phase 3 studies of lumacaftor in combination with ivacaftor that showed statistically significant improvements in lung function (percent predicted forced expiratory volume in one second, or ppFEV 1 ) in people ages 12 and older with cystic fibrosis (CF) who have two copies (homozygous) of the F508del mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene.
Sign-up for - Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements in Lung Function (FEV1) in People with Cystic Fibrosis who have Two Copies of the F508del Mutation investment picks
WAKEFIELD, Mass., June 24, 2014 (GLOBE NEWSWIRE) -- Comverse (Nasdaq:CNSI) , a global leader in telecom business enablement, today announced that United Telecommunication Services (UTS), a leading integrated provider of proven telecommunication technology in the Caribbean, has selected Comverse for a multi-year managed services contract to provide operations and application support services and maintenance for UTS's billing and active customer care solution.
Sign-up for - United Telecommunication Services (UTS) Awards Managed Services Contract to Comverse investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Futures for U.S. stocks fell Tuesday, ahead of a packed schedule of data on the housing market and speeches by Federal Reserve officials.
Sign-up for 2014/6/24 - UPDATE: Stock futures fall before housing data, Fed speeches investment picks
SINGAPORE , June 24, 2014 /PRNewswire/ -- Linktone Ltd.
Sign-up for 2014/6/24 - Linktone Announces Change of Name investment picks
Kofax® Limited (NASDAQ and LSE: KFX), a leading provider of smart process applications for the business critical First Mile™ of customer interactions, today announced that an organization that provides medical products and services throughout North America selected Kofax MarkView® for AP , Kofax Capture™ , Kofax Transformation Modules™ and Kofax Analytics for Capture™ to automate its accounts payable (AP) processes.
Sign-up for 2014/6/24 - North American Medical Products and Services Provider Selects Kofax Solution for AP Automation investment picks
HAMILTON, Bermuda, June 24, 2014 (GLOBE NEWSWIRE) -- Golar LNG Limited (the "Company") (NASDAQ: GLNG) announced today the pricing of its registered offering of 11,000,000 shares of its common stock, par value $1.00 per share, at a price to the public of $54.00 per share.
Sign-up for - Golar LNG Limited Successfully Prices Public Follow-On Offering of its Common Stock investment picks
Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the Southern District of Indiana on behalf of a class (the “Class”) comprising all purchasers of the common stock of Endocyte, Inc. (“Endocyte” or the “Company”) (NASDAQ:ECYT) between March 21, 2014 and May 2, 2014, inclusive (the “Class Period”). Please contact us at (646) 539-8980, or at to discuss this matter.
Sign-up for - INVESTOR ALERT: Class Action Lawsuit against Endocyte, Inc. Announced by Glancy Binkow & Goldberg LLP investment picks
VeroLube, Inc. (“VeroLube” or the “ Company ”), announces today the signing of an extension and amendment to the previously executed stock purchase agreement dated March 10, 2014 (the “Extension”) to acquire Thermo Fluids, Inc. (“Thermo Fluids”) through its wholly owned subsidiary VeroLube USA, Inc. Thermo Fluids, a standalone subsidiary of Nuverra Environmental Solutions, Inc. (“Nuverra”) – (NYSE:NES) based in Scottsdale, Arizona, is the largest western used oil collector and the third-largest collector of used motor oil in the U.S. Thermo Fluids collects approximately 50 million gallons of used motor oil annually from a diverse base of more than 20,000 locations.
Sign-up for - VeroLube’s Acquisition of Thermo Fluids Update investment picks
Sign-up for 2014/6/24 - Boston Pizza International Inc. Declares Dividends investment picks
Sign-up for 2014/6/24 - AutoNation Announces Second Quarter Conference Call and Audio Webcast Scheduled for Thursday, July 17, 2014 investment picks
Affymax, Inc. (AFFY), a biopharmaceutical company, today announced that its Board of Directors has approved the liquidation and dissolution of the company, subject to stockholder approval, and plans to distribute all available cash to its stockholders as soon as legally permitted and reasonably practicable after paying or making reasonable provision for all known and potential liabilities and other obligations of the Company.
Sign-up for - Affymax Board Announces Decision to Dissolve the Company investment picks
AES Corp.
Sign-up for - UPDATE: 10 laggard stocks that could get a -2- investment picks
NEWARK, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC) , a biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications, announced today the closing of its follow-on public offering of 4,600,000 shares of common stock at a public offering price of $30.50 per share.
Sign-up for - Revance Therapeutics Announces Closing of Its Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.


Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: - Texas Instruments ushers in a new era of ultra-low power with new MSP430™ FRAM microcontrollers to - Revance Therapeutics Announces Closing of Its Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices